ImmunityBio, Inc. — Director's Dealing 2019

Dec 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2019-12-12

Reporting Person: Thomas John C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-12	Common Stock	S	10000	$1.9918	Disposed	360069	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13886	Indirect

Footnotes

F1: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2019 by the reporting person.

F2: Represents the weighted average share price of an aggregate total of 10,000 shares sold in the price range of $1.98 to $2.01 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Reported shares held by the John C Thomas Jr. Trustee Susan T Thomas U/W DTD 5/10/96.